Literature DB >> 9423815

Heterozygous beta-thalassemia with thalassemia intermedia phenotype.

D Gasperini1, L Perseu, M A Melis, L Maccioni, M C Sollaino, E Paglietti, A Cao, R Galanello.   

Abstract

In this study we investigated the molecular bases of the beta-thalassemia intermedia phenotype in six patients belonging to two unrelated families of Sardinian descent. Sequence analysis of the beta globin gene from these patients detected, as the sole abnormality, the heterozygosity for the codon 39 nonsense mutation. The A gamma and Ggamma promoters as well as the HS2 and HS3 core sequences of the beta globin LCR from these patients, did not show any non-polymorphic nucleotide variation from the consensus sequence. One of the parents was heterozygous for codon 39 nonsense mutation but showed the beta-thalassemia carrier phenotype; the other was hematologically normal and had an entirely normal beta globin gene sequence. In both families, other members showed the typical hematological phenotype, clinically silent, of heterozygous beta thalassemia. To explain the thalassemia intermedia phenotype, we postulated the presence of an unknown molecular defect interacting with the beta globin gene mutation. Haplotype analysis excluded that this postulated defect lies in the beta globin gene cluster.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9423815     DOI: 10.1002/(sici)1096-8652(199801)57:1<43::aid-ajh7>3.0.co;2-1

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Association of polymorphic pattern of the (AT) × (T)y motif of β-globin gene in North Indian thalassemia patients with variable clinical expression.

Authors:  Vandana Arya; Sarita Agarwal; Mandakini Pradhan
Journal:  Indian J Hematol Blood Transfus       Date:  2010-08-04       Impact factor: 0.900

2.  Association of α globin gene quadruplication and heterozygous β thalassemia in patients with thalassemia intermedia.

Authors:  Maria Carla Sollaino; Maria Elisabetta Paglietti; Lucia Perseu; Nicolina Giagu; Daniela Loi; Renzo Galanello
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.